Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.041.650 |
Chemical and physical data | |
Formula | C15H22N2O2 |
Molar mass | 262.353 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
|
Mepindolol (Betagon) is a non-selective beta blocker. It is used to treat glaucoma.[1]
The first reported synthesis of mepindolol in 1971 used 4-hydroxy-2-methylindole {9) with epichlorohydrin and then isopropylamine to add the sidechain which was known to produce beta blockers, by analogy with drugs discovered by Imperial Chemical Industries, such as propanolol.[2] The requisite intermediate was synthesized in a multi-step procedure from 4-benzyloxyindole-2-carboxylic acid (1) which was converted into (9) by conventional chemistry.[3][4]
β, non-selective | |
---|---|
β1-selective | |
β2-selective | |
α1- + β-selective | |
|
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||